Nuvation Bio Inc Warrants
NUVB.WS
NUVB.WS was delisted on the 10th of February, 2026.
20 hedge funds and large institutions have $7.76M invested in Nuvation Bio Inc Warrants in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
5% more funds holding
Funds holding: 19 → 20 (+1)
0.03% less ownership
Funds ownership: 1.84% → 1.81% (-0.03%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
47% less capital invested
Capital invested by funds: $14.7M → $7.76M (-$6.92M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Clearline Capital
New York
|
+$33.5K |
| 2 |
6CM
683 Capital Management
New York
|
+$10.1K |
| 3 |
Walleye Capital
New York
|
+$2.12K |
| 4 |
Barclays
London,
United Kingdom
|
+$1.93K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$188 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$75.8K |
| 2 |
D.E. Shaw & Co
New York
|
-$66K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$1.95K |
| 4 |
IP
Intellectus Partners
San Francisco,
California
|
-$1.17K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$34 |
NUVB.WS Hedge Fund Activity: Q1 2022 in Review
20 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q1 2022, worth a combined $7.76M — down 47% from $14.7M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NUVB.WS positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Clearline Capital, opening a new position worth an estimated $33.5K. The largest seller was BlackRock, cutting an estimated $75.8K.
- 20 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q1 2022, up from 19 in Q4 2021.
- Funds reported $7.76M of Nuvation Bio Inc Warrants stock for Q1 2022, down 47% quarter-over-quarter.
- 2 funds opened new Nuvation Bio Inc Warrants positions in Q1 2022 and 1 closed out, a net change of +1 holder.
- The largest Nuvation Bio Inc Warrants buyer in Q1 2022 was Clearline Capital, an estimated $33.5K added.
- The largest Nuvation Bio Inc Warrants seller in Q1 2022 was BlackRock, an estimated $75.8K sold.
Based on aggregated 13F filings for Q1 2022.